ALZN
Alzamend Neuro
$1.34
+$0.01 (+0.75%)Jul 27, 2026
Key metrics
The numbers that frame ALZN today
- Market cap
- $6.42M
- P/E (TTM)
- -0.7
- EV / FCF
- -0.7
- ROIC
- 4,082.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.85
- 52wk High
- $3.01
Growth
Revenue and earnings trend for ALZN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ALZN
Is Alzamend Neuro a good buy?
No. Alzamend Neuro has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Alzamend Neuro is selling at a very high price.
What is the market capitalization of ALZN?
Alzamend Neuro's market capitalization is $6.42M.
What is the P/E ratio for ALZN stock?
Alzamend Neuro's current P/E ratio is -0.7.
What is the 52-week high for ALZN stock?
The 52-week high for Alzamend Neuro is $3.01. The current close of $1.34 is 55.5% below that high.
What is the 52-week low for ALZN stock?
The 52-week low for Alzamend Neuro is $0.85. The current close of $1.34 is 57.6% above that low.
Does ALZN stock pay dividends?
Alzamend Neuro does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ALZN?
Alzamend Neuro's Debt / Equity ratio is 0.